Drug costs should be a ‘prominent issue’ in Trump trade talks: Mount Sinai Health CEO
The Trump administration should make the rising cost of medicine a leading issue in trade talks with countries around the world, Mount Sinai Health System CEO Kenneth Davis told CNBC on Friday. “We marvel at the fact that U.S. drug costs are two to six times higher than they are in the rest of the… Read More »